Established in May, 2005, Weihai Disu Pharmaceutical Co., Ltd., a subsidiary of Disha Pharmaceutical Group, is a national high-tech enterprise majoring in R&D, manufacturing and marketing of APIs and intermediates.
Relying on the R&D strength of Disha Pharmaceutical Group, Weihai Disu Pharmaceutical Co., Ltd. has built an institute with 100 researchers. Besides that, four other research institutes in Disha Group will constantly provide Weihai Disu with technical supports of science research and process optimization.
Weihai Disu performs strictly to the standards of Ch.P, Eh.P, USP and JP. The API registrations in EU, Japan, Korea and India are also in process. Glipizide has been registered in EU. Disu Pharmaceutical Co., Ltd. was among the first pharmaceutical enterprises in China to got 2010 GMP certificate .Our management philosophy and technical level are one of the best in China.
Disu Pharmaceutical Co., Ltd. invests a new plant in Gushan Town, covering an area of 170,000 square meters, with construction standard complies strictly with the requirements of EU and FDA. Gushan Plant will be able to manufacture over 100 kinds of products in three years. The producing capacity will be over 300 tons.
We can provide high-quality products, high-efficiency OEM and high-sincerity technical cooperation to customers. Looking forward to cooperating with you on a mutual benefit to built a brighter future.
